BioGaia Pharma AB
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (NCT05118919) | BioGaia Pharma AB | 2022-02-09 |
| Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications (NCT05133076) | BioGaia Pharma AB | 2022-01-20 |
Track BioGaia Pharma AB automatically
Every clearance here is in the API, with alerts when new ones post.